8-K//Current report
SAB Biotherapeutics, Inc. 8-K
Accession 0000950170-25-097078
$SABSCIK 0001833214operating
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 7:31 AM ET
Size
1.7 MB
Accession
0000950170-25-097078
Documents
- 8-Ksabs-20250721.htmPrimary
8-K
- EX-3.1sabs-ex3_1.htm
EX-3.1
- EX-4.1sabs-ex4_1.htm
EX-4.1
- EX-4.2sabs-ex4_2.htm
EX-4.2
- EX-10.1sabs-ex10_1.htm
EX-10.1
- EX-10.2sabs-ex10_2.htm
EX-10.2
- EX-10.3sabs-ex10_3.htm
EX-10.3
- EX-10.4sabs-ex10_4.htm
EX-10.4
- EX-99.1sabs-ex99_1.htm
EX-99.1
- EX-101.SCHsabs-20250721.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-097078-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLsabs-20250721_htm.xml
IDEA: XBRL DOCUMENT
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001833214
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 7:31 AM ET
- Size
- 1.7 MB